Our patient is a 54-year-old male presented with visual loss and loss of libido, diagnosed with macroprolactinoma, with institution of D2-agonist therapy, prolactin levels normalized but tumor continued to grow.
Clinical History
Pre-Operative Imaging
Operative Findings
Surgical Pathology
Post-Operative Course
Discussion
Molitch ME. Dopamine resistance of prolactinomas. Pituitary. 2003;6(1):19-27. Review.
Gillam MP, Middler S, Freed DJ, Molitch ME. The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab. 2002 Oct;87(10):4447-51.
Lim JS, Ku CR, Lee MK, Kim TS, Kim SH, Lee EJ. A case of fugitive acromegaly, initially presented as invasive prolactinoma. Endocrine. 2010 Aug;38(1):1-5. Epub 2010Apr 24.
